Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.930
+0.030 (1.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bluejay Diagnostics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 1 | 3 | 2 | 8 | 50 | |
| Market Cap Growth | 39.71% | -55.02% | 78.09% | -80.24% | -84.67% | - | |
| Enterprise Value | -3 | -2 | -3 | -3 | -5 | 52 | |
| Last Close Price | 1.93 | 2.67 | 19.48 | 1952.00 | 12156.77 | 81920.00 | |
| PS Ratio | - | - | - | - | 30.70 | - | |
| PB Ratio | 0.20 | 0.20 | 0.47 | 0.52 | 0.66 | 2.45 | |
| P/TBV Ratio | 0.33 | 0.20 | 0.47 | 0.52 | 0.66 | 2.45 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.13 | 0.04 | - | |
| Net Debt / Equity Ratio | -0.84 | -0.84 | -0.71 | -0.63 | -0.83 | -0.93 | |
| Net Debt / EBITDA Ratio | 0.74 | 0.74 | 0.57 | 0.19 | 1.05 | 6.18 | |
| Net Debt / FCF Ratio | 0.81 | 0.81 | 0.50 | 0.20 | 1.07 | 4.34 | |
| Asset Turnover | - | - | - | - | 0.01 | - | |
| Quick Ratio | 4.62 | 4.62 | 5.31 | 1.25 | 6.17 | 29.90 | |
| Current Ratio | 4.88 | 4.88 | 6.05 | 1.82 | 7.19 | 32.43 | |
| Return on Equity (ROE) | -117.02% | -117.02% | -178.98% | -137.90% | -58.25% | -34.79% | |
| Return on Assets (ROA) | -62.76% | -62.76% | -77.75% | -70.09% | -33.72% | -17.92% | |
| Return on Capital Employed (ROCE) | -115.30% | -115.30% | -122.60% | -332.90% | -78.40% | -15.80% | |
| Earnings Yield | -342.94% | -565.81% | -286.84% | -658.83% | -121.58% | -6.99% | |
| FCF Yield | -311.83% | -514.49% | -302.07% | -596.89% | -116.93% | -8.80% | |
| Buyback Yield / Dilution | -879.42% | -879.42% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.